Ubiquitech Software Corp UBQU
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if UBQU is a good fit for your portfolio.
News
-
Ubiquitech Software's Subsidiary, Innovative Outcomes, Revolutionizes Healthcare Landscape With Clinic-Based Model, Anticipates Surge in Revenue Growth
-
Innovative Outcomes (OTC:UBQU) Announces Distribution Agreement With MDM Wound Ventures to Distribute New EZE Debride System to Healthcare Professionals in 4.95 Billion Dollar Market
-
CEO of Innovative Outcomes, Inc., (OTC:UBQU) Offers Open Letter to Shareholders and Investors
-
Ubiquitech Software Corp. (OTC:UBQU) Announces Strategic Acquisition of Innovative Outcomes, Inc., an Established Leader in the Multi-Billion Dollar Medical Wound Care Segment
-
Ubiquitech Software Corp. (OTC: UBQU) Pending Acquisition, Innovative Outcomes, Inc. Creates New Pilot Program to be Introduced to Health Clinics Nationwide
-
Ubiquitech Software Corp. (OTC: UBQU) Unveils Groundbreaking Lifestyle Video Marketing Initiative for Innovative Outcomes Driving Rapid Company Growth
-
Ubiquitech Software Corp. (OTC: UBQU) Poised for Accelerated Growth With Pending Acquisition Posting Over $5,000,000 in Annual Sales
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $1.45 Mil
- Volume/Avg
- 1.9 Mil / 25.4 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Ubiquitech Software Corp is a United States-based multi-media, multi-faceted company. It is engaged in utilizing world-wide internet marketing, direct response television, radio, and traditional marketing to drive traffic to the new industries. The company also focuses on developing Cannabidiol (CBD) Hemp derived products. It owns the proprietary CBD brand CannazALL. The company offers the products through its internally designed and operated web portal.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- 2
- Website
- https://www.cannazall.com
Valuation
Metric
|
UBQU
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric
|
UBQU
|
---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.17 |
Interest Coverage | — |
Quick Ratio
UBQU
Profitability
Metric
|
UBQU
|
---|---|
Return on Assets (Normalized) | −12,986.89% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
No chart available
Drug Manufacturers - Specialty & Generic Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Zwgtrzjkp | Hgdbj | $70.0 Bil | |
MKKGY
| Merck KGaA ADR | Tgcdmjpyb | Krdfgc | $68.1 Bil | |
HLN
| Haleon PLC ADR | Wrhpxwr | Rrkf | $36.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Yrmmhgjd | Wqtd | $14.3 Bil | |
VTRS
| Viatris Inc | Knzbrsqn | Cxbv | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Xsngzvqw | Nmkjf | $12.0 Bil | |
CTLT
| Catalent Inc | Ptnphsnzg | Hpjndyw | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Xmlggjtj | Kxhn | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Rnwxgfx | Dvbc | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Hqjpwqmw | Qxssqbk | $3.4 Bil |